Product
EffCaMgCit
Aliases
Effervescent calcium magnesium citrate
2 clinical trials
3 indications
Indication
Chronic Kidney Disease Stage 5Indication
OsteoporosisIndication
HypomagnesemiaClinical trial
Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage VStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Effervescent Calcium Magnesium Citrate to Prevent Mineral Metabolism and Renal Complications of Chronic Proton Pump Inhibitor TherapyStatus: Recruiting, Estimated PCD: 2025-09-30